Signaling Pathways
| Product Number | Product Name | CAS RN | Molecular Formula | Application |
| CL2088 | Afuresertib(GSK2110183;LAE002) | 1047644-62-1 | C18H17Cl2FN4OS |
|
| CL2749A | GalNac-L96(triethylamine salt) | 1159408-62-4 | C127H194N12O45 | |
| CL2485 | PD184352(CI-1040) | 212631-79-3 | C17H14ClF2IN2O2 | |
| CL2748 | Molibresib(I-BET-762;GSK525762;GSK525762A) | 1260907-17-2 | C22H22ClN5O2 | |
| CL2747 | Selonsertib(GS-4997) | 1448428-04-3 | C24H24FN7O |
|
| CL1332 | Alpelisib | 1217486-61-7 | C19H22F3N5O2S |
|
| CL2665 | L-742001 hydrochloride | 174605-64-2 | C23H25Cl2NO4 | |
| CL2374 | Rapamycin(Sirolimus) | 53123-88-9 | C51H79NO13 | |
| CL2746 | Lenacapavir(GS-6207) | 2189684-44-2 | C39H32ClF10N7O5S2 | |
| CL2744 | Gedatolisib(PKI-587; PF-05212384) | 1197160-78-3 | C32H41N9O4 | |
| CL2427 | Lusutrombopag | 1110766-97-6 | C29H32Cl2N2O5S | |
| CL1844 | Eribulin Mesylate | 441045-17-6 | C41H63NO14S | |
| CL2714 | WST-8 | 193149-74-5 | C20H13N6NaO11S2 | |
| CL2716 | Streptavidin | 9013-20-1 | ||
| CL2739 | Deruxtecan(DS-8201a) | 1599440-13-7 | C52H56FN9O13 |
Products
- Category
- Active Pharmaceutical Ingredients
- Pharmaceutical Intermediates
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies & Fusion Protein
- Bioactive Small Molecules
- Stable Isotope Labelled Compounds
- Cytokines
- Dye Reagents
- Drug Impurities & Metabolites
- Natural Products
- Building Blocks & Specialty Chemicals
